Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andenmatten R., Gonvers M. Sophisticated vitreoretinal surgery in patients with a healthy fellow eye. An 11-year retrospective study. Graefes Arch Clin Exp Ophthalmol. 1993 Sep;231(9):495–499. doi: 10.1007/BF00921113. [DOI] [PubMed] [Google Scholar]
- Binder S., Bonnet M., Velikay M., Gerard J. P., Stolba U., Wedrich A., Hohenberg H. Radiation therapy in proliferative vitreoretinopathy. A prospective randomized study. Graefes Arch Clin Exp Ophthalmol. 1994 Apr;232(4):211–214. doi: 10.1007/BF00184007. [DOI] [PubMed] [Google Scholar]
- Binder S., Skorpik C., Paroussis P., Kulnig W., Menapace R., Prokesch E. High-energy electrons used to inhibit experimental intraocular proliferation and detachment. Ophthalmologica. 1987;195(3):128–134. doi: 10.1159/000309801. [DOI] [PubMed] [Google Scholar]
- Blumenkranz M. S., Claflin A., Hajek A. S. Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation. Arch Ophthalmol. 1984 Apr;102(4):598–604. doi: 10.1001/archopht.1984.01040030470029. [DOI] [PubMed] [Google Scholar]
- Blumenkranz M. S., Ophir A., Claflin A. J., Hajek A. Fluorouracil for the treatment of massive periretinal proliferation. Am J Ophthalmol. 1982 Oct;94(4):458–467. doi: 10.1016/0002-9394(82)90239-2. [DOI] [PubMed] [Google Scholar]
- Blumenkranz M., Hernandez E., Ophir A., Norton E. W. 5-fluorouracil: new applications in complicated retinal detachment for an established antimetabolite. Ophthalmology. 1984 Feb;91(2):122–130. doi: 10.1016/s0161-6420(84)34318-4. [DOI] [PubMed] [Google Scholar]
- Campochiaro P. A., Glaser B. M. Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells. Arch Ophthalmol. 1985 Apr;103(4):576–579. doi: 10.1001/archopht.1985.01050040118034. [DOI] [PubMed] [Google Scholar]
- Campochiaro P. A., Jerdan J. A., Glaser B. M. Serum contains chemoattractants for human retinal pigment epithelial cells. Arch Ophthalmol. 1984 Dec;102(12):1830–1833. doi: 10.1001/archopht.1984.01040031488029. [DOI] [PubMed] [Google Scholar]
- Campochiaro P. A., Jerdon J. A., Glaser B. M. The extracellular matrix of human retinal pigment epithelial cells in vivo and its synthesis in vitro. Invest Ophthalmol Vis Sci. 1986 Nov;27(11):1615–1621. [PubMed] [Google Scholar]
- Chandler D. B., Hida T., Sheta S., Proia A. D., Machemer R. Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment. Graefes Arch Clin Exp Ophthalmol. 1987;225(4):259–265. doi: 10.1007/BF02150144. [DOI] [PubMed] [Google Scholar]
- Connor T. B., Jr, Roberts A. B., Sporn M. B., Danielpour D., Dart L. L., Michels R. G., de Bustros S., Enger C., Kato H., Lansing M. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest. 1989 May;83(5):1661–1666. doi: 10.1172/JCI114065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gaudric A., Glacet-Bernard A., Clément G., Falquerho L., Barritault D., Coscas G. Transforming Growth Factor bêta dans le vitré de patients présentant une prolifération épirétinienne. Ophtalmologie. 1990 Jan-Feb;4(1):51–52. [PubMed] [Google Scholar]
- Grierson I., Rahi A. H. Structural basis of contraction in vitreal fibrous membranes. Br J Ophthalmol. 1981 Nov;65(11):737–749. doi: 10.1136/bjo.65.11.737. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hiscott P., Waller H. A., Grierson I., Butler M. G., Scott D. Local production of fibronectin by ectopic human retinal cells. Cell Tissue Res. 1992 Jan;267(1):185–192. doi: 10.1007/BF00318703. [DOI] [PubMed] [Google Scholar]
- Hui Y. N., Liang H. C., Cai Y. S., Kirchhof B., Heimann K. Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages. Graefes Arch Clin Exp Ophthalmol. 1993 Feb;231(2):109–114. doi: 10.1007/BF00920223. [DOI] [PubMed] [Google Scholar]
- Kampik A., Kenyon K. R., Michels R. G., Green W. R., de la Cruz Z. C. Epiretinal and vitreous membranes. Comparative study of 56 cases. Arch Ophthalmol. 1981 Aug;99(8):1445–1454. doi: 10.1001/archopht.1981.03930020319025. [DOI] [PubMed] [Google Scholar]
- Kuriyama S., Ohuchi T., Yoshimura N., Honda Y., Hiraoka M., Abe M. Evaluation of radiation therapy for experimental proliferative vitreoretinopathy in rabbits. Graefes Arch Clin Exp Ophthalmol. 1990;228(6):552–555. doi: 10.1007/BF00918489. [DOI] [PubMed] [Google Scholar]
- Laqua H., Machemer R. Glial cell proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol. 1975 Oct;80(4):602–618. doi: 10.1016/0002-9394(75)90390-6. [DOI] [PubMed] [Google Scholar]
- Lewis H., Aaberg T. M., Abrams G. W., McDonald H. R., Williams G. A., Mieler W. F. Subretinal membranes in proliferative vitreoretinopathy. Ophthalmology. 1989 Sep;96(9):1403–1415. doi: 10.1016/s0161-6420(89)32712-6. [DOI] [PubMed] [Google Scholar]
- Machemer R., Buettner H., Norton E. W., Parel J. M. Vitrectomy: a pars plana approach. Trans Am Acad Ophthalmol Otolaryngol. 1971 Jul-Aug;75(4):813–820. [PubMed] [Google Scholar]
- Machemer R., Laqua H. Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol. 1975 Jul;80(1):1–23. doi: 10.1016/0002-9394(75)90862-4. [DOI] [PubMed] [Google Scholar]
- McCormack P., Simcock P. R., Charteris D., Lavin M. J. Is surgery for proliferative vitreoretinopathy justifiable? Eye (Lond) 1994;8(Pt 1):75–76. doi: 10.1038/eye.1994.14. [DOI] [PubMed] [Google Scholar]
- Radtke N. D., Weinsieder A. D., Ballou R. J. Pharmacological therapy for proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol. 1986;224(3):230–233. doi: 10.1007/BF02143060. [DOI] [PubMed] [Google Scholar]
- Roth A. M., Foos R. Y. Surface wrinkling retinopathy in eyes enucleated at autopsy. Trans Am Acad Ophthalmol Otolaryngol. 1971 Sep-Oct;75(5):1047–1058. [PubMed] [Google Scholar]
- Schwartz D., de la Cruz Z. C., Green W. R., Michels R. G. Proliferative vitreoretinopathy. Ultrastructural study of 20 retroretinal membranes removed by vitreous surgery. Retina. 1988;8(4):275–281. [PubMed] [Google Scholar]
- Scott J. D. Duke-Elder lecture. Prevention and perspective in retinal detachment. Eye (Lond) 1989;3(Pt 5):491–515. doi: 10.1038/eye.1989.82. [DOI] [PubMed] [Google Scholar]
- Smith R. S., Van Heuven W. A., Streeten B. Vitreous membranes. A light and electron microscopical study. Arch Ophthalmol. 1976 Sep;94(9):1556–1560. doi: 10.1001/archopht.1976.03910040390014. [DOI] [PubMed] [Google Scholar]
- Sternberg P., Jr, Machemer R. Subretinal proliferation. Am J Ophthalmol. 1984 Oct 15;98(4):456–462. doi: 10.1016/0002-9394(84)90131-4. [DOI] [PubMed] [Google Scholar]
- Sullivan P. M., Luff A. J., Julious S. A., Canning C. R. Patient satisfaction following vitreoretinal surgery. Eye (Lond) 1993;7(Pt 3):433–435. doi: 10.1038/eye.1993.86. [DOI] [PubMed] [Google Scholar]
- Tano Y., Chandler D., Machemer R. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol. 1980 Dec;90(6):810–816. doi: 10.1016/s0002-9394(14)75196-7. [DOI] [PubMed] [Google Scholar]
- Van Horn D. L., Aaberg T. M., Machemer R., Fenzl R. Glial cell proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol. 1977 Sep;84(3):383–393. doi: 10.1016/0002-9394(77)90684-5. [DOI] [PubMed] [Google Scholar]
- Weller M., Heimann K., Wiedemann P. Immunhistochemische Befunde bei proliferativen Netzhauterkrankungen--zur Bedeutung von Fibronektin, Makrophagen und Transferrin. Fortschr Ophthalmol. 1989;86(2):121–123. [PubMed] [Google Scholar]
- Weller M., Wiedemann P., Bresgen M., Heimann K. Vitronektin: Mediator der Zelladhäsion bei der proliferativen Vitreoretinopathie? Fortschr Ophthalmol. 1990;87(2):221–225. [PubMed] [Google Scholar]
- Wiedemann P. Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv Ophthalmol. 1992 Mar-Apr;36(5):373–384. doi: 10.1016/0039-6257(92)90115-a. [DOI] [PubMed] [Google Scholar]
- Wiedemann P., Leinung C., Hilgers R. D., Heimann K. Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol. 1991;229(2):150–152. doi: 10.1007/BF00170548. [DOI] [PubMed] [Google Scholar]
- Wiedemann P., Lemmen K., Schmiedl R., Heimann K. Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy. Am J Ophthalmol. 1987 Jul 15;104(1):10–14. doi: 10.1016/0002-9394(87)90286-8. [DOI] [PubMed] [Google Scholar]
- Wilson-Holt N., Khaw P., Savage F., Grierson I. The chemoattractant activity of the vitreous to human scleral fibroblasts following retinal detachment and proliferative vitreoretinopathy. Br J Ophthalmol. 1992 Mar;76(3):159–162. doi: 10.1136/bjo.76.3.159. [DOI] [PMC free article] [PubMed] [Google Scholar]